ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P8
Near historical low
vs 2Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -165.60% |
| Q3 2025 | 16.15% |
| Q2 2025 | 214.70% |
| Q1 2025 | -49.67% |
| Q4 2024 | -36.15% |
| Q3 2024 | 152.85% |
| Q2 2024 | -13.98% |
| Q1 2024 | -65.95% |
| Q4 2023 | 244.84% |
| Q3 2023 | -818.88% |
| Q2 2023 | 145.73% |
| Q1 2023 | 24.82% |
| Q4 2022 | -3181.16% |
| Q3 2022 | 94.46% |
| Q2 2022 | 82.80% |
| Q1 2022 | -230.14% |
| Q4 2021 | -35.49% |
| Q3 2021 | 32.63% |
| Q2 2021 | 57.89% |
| Q1 2021 | -118.82% |
| Q4 2020 | -20.60% |
| Q3 2020 | 38.20% |
| Q2 2020 | 24.73% |
| Q1 2020 | -64.95% |
| Q4 2019 | -57.59% |
| Q3 2019 | 50.91% |
| Q2 2019 | 40.17% |
| Q1 2019 | -64.22% |
| Q4 2018 | 7.57% |
| Q3 2018 | -3.44% |
| Q2 2018 | 9.64% |
| Q1 2018 | -51.32% |
| Q4 2017 | 48.81% |
| Q3 2017 | 0.85% |
| Q2 2017 | 16.64% |
| Q1 2017 | -11.82% |
| Q4 2016 | -28.27% |
| Q3 2016 | 13.19% |
| Q2 2016 | -37.69% |
| Q1 2016 | -18.69% |